Sign in
4

Changes in Ownership

Tyra Biosciences, Inc. Filed Acc 0000950170-24-074996

Director acquired 61,392 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
KAPLAN GILLA Director 2024-06-13 Option exercise +61,392 $0.61 $37,449 89,623 D
Derivatives
KAPLAN GILLA Director 2024-06-13 Option exercise · Stock Option (Right to Buy) −61,392 0 D
Loading xslF345X05/ownership.xml…